EP
CYAD

Eversept Partners’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History

Eversept Partners’s Portfolio CYAD Stock Details CYAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-12,840
Closed -$382K – 75
2018
Q2 		$382K Buy
+12,840
New +$382K 0.17% 61